Literature DB >> 35635626

Small Is Big: Why the Analysis of the Fecal Microbiome Provides Little Important Information on IBS Severity.

Connie J Oh1, Ali Rezaie2,3.   

Abstract

Entities:  

Year:  2022        PMID： 35635626     DOI： 10.1007/s10620-022-07551-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  11 in total

1.  Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Authors:  Mark Pimentel; Anthony Lembo; William D Chey; Salam Zakko; Yehuda Ringel; Jing Yu; Shadreck M Mareya; Audrey L Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

Review 2.  Irritable bowel syndrome: a microbiome-gut-brain axis disorder?

Authors:  Paul J Kennedy; John F Cryan; Timothy G Dinan; Gerard Clarke
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

3.  Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.

Authors:  Sofie Ingdam Halkjær; Alice Højer Christensen; Bobby Zhao Sheng Lo; Patrick Denis Browne; Stig Günther; Lars Hestbjerg Hansen; Andreas Munk Petersen
Journal:  Gut       Date:  2018-07-06       Impact factor: 23.059

Review 4.  Irritable bowel syndrome: a clinical review.

Authors:  William D Chey; Jacob Kurlander; Shanti Eswaran
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

Review 5.  Serotonin, tryptophan metabolism and the brain-gut-microbiome axis.

Authors:  S M O'Mahony; G Clarke; Y E Borre; T G Dinan; J F Cryan
Journal:  Behav Brain Res       Date:  2014-07-29       Impact factor: 3.332

Review 6.  The Brain-Gut-Microbiome Axis.

Authors:  Clair R Martin; Vadim Osadchiy; Amir Kalani; Emeran A Mayer
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-04-12

7.  Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome.

Authors:  Anthony A Fodor; Mark Pimentel; William D Chey; Anthony Lembo; Pamela L Golden; Robert J Israel; Ian M Carroll
Journal:  Gut Microbes       Date:  2018-07-18

8.  Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.

Authors:  Ali Rezaie; Zeev Heimanson; Richard McCallum; Mark Pimentel
Journal:  Am J Gastroenterol       Date:  2019-12       Impact factor: 10.864

9.  Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence?

Authors:  Eric Shah; Ali Rezaie; Mark Riddle; Mark Pimentel
Journal:  Ann Gastroenterol       Date:  2014

10.  Mapping the Segmental Microbiomes in the Human Small Bowel in Comparison with Stool: A REIMAGINE Study.

Authors:  Gabriela G S Leite; Stacy Weitsman; Gonzalo Parodi; Shreya Celly; Rashin Sedighi; Maritza Sanchez; Walter Morales; Maria Jesus Villanueva-Millan; Gillian M Barlow; Ruchi Mathur; Simon K Lo; Laith H Jamil; Shirley Paski; Ali Rezaie; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2020-03-06       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.